Advertisement

The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol

Lexiva And Truvada Combination

Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts

beginning regimen of Norvir, Lexiva, Truvada

My son is HIV positiveand in az prison. His doctors have decidied with his approval to start him on meds. His CD4 count is 325. They are starting him out with the generics for Lexiva, Novir, and Truvada. Is this a good combination that will cause...
Gerald Pierone, M.D.

Response from Gerald Pierone, M.D.

AIDS Research and Treatment Center of the Treasure Coast
Hello, and thanks for posting. This is a good starting combination which has a high likelihood of working for your son. There are no generics for these medications so he will be getting branded products. Side effects may occur with any regimen and... Read more »

Switching to Lexiva/Telzir, Norvir and Truvada

Two years ago I've started taking Kaletra and Combivir. It works very fine for me, nearly... Read more »

Is Boosted Lexiva + Truvada + Ziagen more likely to fail?

Hello there! First, thanks for all the great work that you all do on this website! After six years... Read more »
Articles
Henry J. Kaiser Family Foundation

Gilead's Combination of Antiretrovirals Truvada, Sustiva Not Bioequivalent to Two Drugs Alone, Study Says

Gilead on Tuesday announced that its reformulation of a fixed-dose combination antiretroviral drug combining the company's Truvada with Bristol-Myers Squibb 's drug Sustiva is not bioequivalent to the two drugs when used separately, AFX... Read more »
Henry J. Kaiser Family Foundation

Gilead Gains European Approval to Market Combination Antiretroviral Drug Truvada

Foster City, Calif.-based biotech company Gilead on Wednesday received approval from the European Commission to market its combination antiretroviral drug Truvada in all 25 European Union countries, the AP/ Forbes reports. Truvada is a... Read more »
Henry J. Kaiser Family Foundation

Gilead to Make Antiretroviral Drug Truvada Available to 68 Developing Countries at Not-for-Profit Price

Gilead Sciences announced on Wednesday that it will offer its once-daily, fixed-dose combination antiretroviral drug Truvada through its Global Access Program to 68 developing countries at the not-for-profit price of 99 cents per patient, per day... Read more »
U.S. Food and Drug Administration

FDA Approval of Lexiva Oral Suspension and Label Changes for Pediatric Patients and Patients With Hepatic Impairment

On June 14, 2007, the Food and Drug Administration approved a new formulation of Lexiva. Lexiva (fosamprenavir calcium) is now available as an oral suspension (50-mg/mL). The package insert was updated to include information on this new formulation... Read more »
Connect With Others

New combined Truvada/Sustiva combination

Posted by Anonymous, 3 Replies
Hi.
Just wondered if anybody knew as to when the above co-formulated combo will be available? I s it this year?
I am starting with Truvada + Sustiva, but as I not keen on taking tablets anyway, I would rather take just 1 tablet instead of 2.
Thank you Read more »

Sustiva + Truvada combination

Posted by richwales, 6 Replies
Im a 26 y/o male living in UK whos been on sustiva and truvada for 4 months now my Cd4 and viral load are doing great (gone from 14% 245 to 19% 472, and 18,200 to undectable) just finding the side affects of sustiva really can be hard to cope with,... Read more »

drugs that can be used with norvair and truvada

Posted by Anonymous, 5 Replies
I am resistant to Sustiva and have a rash because of the Reyataz. what other combinations of drugs can be used with truvada and norvair? Read more »

Starting Therapy Need Info-Lexiva/Combivir

Posted by dretti, 3 Replies
I tested+ a month ago,still adapting,my doc wants to start therapy.Any experience from anybody taking lexiva/combivir
Any side effects experienced,my major fear, any changes in your physical appearence.Anyone with any advice would greatly be... Read more »

Advertisement